Annual Secretarial Compliance report for the year ended March 31, 2025
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare has submitted its Annual Secretarial Compliance Report for FY25, confirming overall compliance with SEBI regulations and the Companies Act. The report highlights two minor instances of non-compliance: (1) a one-day delay in submitting related party transaction disclosures under Regulation 23(9), for which the company paid a Rs 5,000 fine plus GST to both BSE and NSE, and (2) a delay in intimating the schedule of an investors/analysts' meet held in June 2024 under Regulation 30, which led to cautionary letters from the exchanges. The company noted these at its Board meeting on May 20, 2025, and has taken steps to prevent recurrence. No other material non-compliances or actions by SEBI/stock exchanges were reported, and no statutory auditor resigned during the year.
This is a routine annual compliance filing with no material concerns. The non-compliances were minor technical lapses involving negligible fines and cautionary letters, both already resolved, with no expected impact on stock price or shareholder value.